International Journal of Phytomedicine and Phytotherapy
From: In vitro and in vivo evaluation of pharmacological potentials of Campsis radicans L
Treatment | % Blood glucose reduction | ||
---|---|---|---|
After 1 h | After 2 h | After 3 h | |
Glibenclamide (2 mg/kg b.w.) | 33.99 ± 7.55 | 24.35 ± 3.69 | 39.82 ± 2.61** |
PESF (200 mg/kg b.w.) | 9.88 ± 4.87 | 52.17 ± 3.71* | 14.16 ± 3.15* |
PESF (400 mg/kg b.w.) | 19.76 ± 11.78 | 53.04 ± 3.69** | 16.81 ± 15.65 |
DMSF (200 mg/kg b.w.) | 27.27 ± 10.16 | 43.48 ± 2.84** | 43.36 ± 4.40** |
DMSF (400 mg/kg b.w.) | 26.48 ± 6.22 | 59.13 ± 3.95** | 18.58 ± 1.45** |
EASF (200 mg/kg b.w.) | 34.39 ± 12.91 | 43.48 ± 2.56** | 8.85 ± 14.61* |
EASF (400 mg/kg b.w.) | 14.62 ± 7.27 | 48.70 ± 4.66** | 30.09 ± 3.82** |